ATR12-351

· Azitra Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATR12-351, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome [Phase 1]